Reference |
---|
Zhou H, Wang X, Zhang B. Depression of lncRNA NEAT1 Antagonizes LPS-Evoked Acute Injury and Inflammatory Response in Alveolar Epithelial Cells via HMGB1-RAGE Signaling. Mediators Inflamm. 2020;2020:8019467 pubmed publisher
|
Wang L, Zhu X, Luo Y, Wu Y, Dong N, Tong Y, et al. Sestrin2 protects dendritic cells against endoplasmic reticulum stress-related apoptosis induced by high mobility group box-1 protein. Cell Death Dis. 2020;11:125 pubmed publisher
|
Shu Z, Miao X, Tang T, Zhan P, Zeng L, Jiang Y. The GSK‑3β/β‑catenin signaling pathway is involved in HMGB1‑induced chondrocyte apoptosis and cartilage matrix degradation. Int J Mol Med. 2020;45:769-778 pubmed publisher
|
Shang J, Liu W, Yin C, Chu H, Zhang M. Cucurbitacin E ameliorates lipopolysaccharide-evoked injury, inflammation and MUC5AC expression in bronchial epithelial cells by restraining the HMGB1-TLR4-NF-κB signaling. Mol Immunol. 2019;114:571-577 pubmed publisher
|
Zhang L, Yang X, Jiang G, Yu Y, Wu J, Su Y, et al. HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway. Int J Mol Med. 2019;44:885-892 pubmed publisher
|
Ma C, Chen H, Zhang S, Yan Y, Wu R, Wang Y, et al. Exosomal and extracellular HMGB1 have opposite effects on SASH1 expression in rat astrocytes and glioma C6 cells. Biochem Biophys Res Commun. 2019;518:325-330 pubmed publisher
|
Sun S, Cai B, Li Y, Su W, Zhao X, Gong B, et al. HMGB1 and Caveolin-1 related to RPE cell senescence in age-related macular degeneration. Aging (Albany NY). 2019;11:4323-4337 pubmed publisher
|
Mohammad G, Abdelaziz G, Siddiquei M, Ahmad A, De Hertogh G, Abu El Asrar A. Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy. Curr Eye Res. 2019;44:1133-1143 pubmed publisher
|
Chen B, Li Y, Liu Y, Xu Z. circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells. J Cell Physiol. 2019;234:21249-21259 pubmed publisher
|
Yang S, Lee W, Lee B, Lee C, Park E, Ku S, et al. Aloin Reduces HMGB1-Mediated Septic Responses and Improves Survival in Septic Mice by Activation of the SIRT1 and PI3K/Nrf2/HO-1 Signaling Axis. Am J Chin Med. 2019;47:613-633 pubmed publisher
|
Manganelli V, Truglia S, Capozzi A, Alessandri C, Riitano G, Spinelli F, et al. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome. Front Immunol. 2019;10:460 pubmed publisher
|
Nicaise A, Wagstaff L, Willis C, Paisie C, Chandok H, Robson P, et al. Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis. Proc Natl Acad Sci U S A. 2019;116:9030-9039 pubmed publisher
|
Tao X, Sun M, Chen M, Ying R, Su W, Zhang J, et al. HMGB1-modified mesenchymal stem cells attenuate radiation-induced vascular injury possibly via their high motility and facilitation of endothelial differentiation. Stem Cell Res Ther. 2019;10:92 pubmed publisher
|
Corneth O, Schaper F, Luk F, Asmawidjaja P, Mus A, Horst G, et al. Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice. Sci Rep. 2019;9:4032 pubmed publisher
|
Tamada K, Nakajima S, Ogawa N, Inada M, Shibasaki H, Sato A, et al. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses. Biochem Biophys Res Commun. 2019;: pubmed publisher
|
Lee W, Yuseok O, Lee C, Jeong S, Lee J, Baek M, et al. Suppressive activities of KC1-3 on HMGB1-mediated septic responses. Biochem Pharmacol. 2019;163:260-268 pubmed publisher
|
Hua S, Ma M, Fei X, Zhang Y, Gong F, Fang M. Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis. Int Immunopharmacol. 2019;68:145-155 pubmed publisher
|
Wietzorrek G, Drexel M, Trieb M, Santos Sierra S. Anti-inflammatory activity of small-molecule antagonists of Toll-like receptor 2 (TLR2) in mice. Immunobiology. 2019;224:1-9 pubmed publisher
|
Nitta T, Kanoh H, Inamori K, Suzuki A, Takahashi T, Inokuchi J. Globo-series glycosphingolipids enhance Toll-like receptor 4-mediated inflammation and play a pathophysiological role in diabetic nephropathy. Glycobiology. 2019;29:260-268 pubmed publisher
|
Lee W, Yuseok O, Yang S, Lee B, Lee J, Park E, et al. JH-4 reduces HMGB1-mediated septic responses and improves survival rate in septic mice. J Cell Biochem. 2019;120:6277-6289 pubmed publisher
|
Qu J, Zhang Z, Zhang P, Zheng C, Zhou W, Cui W, et al. Downregulation of HMGB1 is required for the protective role of Nrf2 in EMT-mediated PF. J Cell Physiol. 2019;234:8862-8872 pubmed publisher
|
Tian Y, Charles E, Yan Z, Wu D, French B, Kron I, et al. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway. J Thorac Cardiovasc Surg. 2018;: pubmed publisher
|
Nestor J, Arinuma Y, Huerta T, Kowal C, Nasiri E, Kello N, et al. Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors. J Exp Med. 2018;215:2554-2566 pubmed publisher
|
Li C, Zhang Y, Cheng X, Yuan H, Zhu S, Liu J, et al. PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. Dev Cell. 2018;46:441-455.e8 pubmed publisher
|
Liu Q, Wang Y, Wu Z, Shi Z, Wu X, Chen X, et al. High Mobility Group Protein 1 Reverses Immune System Paralysis in Late-Phase Sepsis. Infect Immun. 2018;86: pubmed publisher
|
Kimura A, Kitajima M, Nishida K, Serada S, Fujimoto M, Naka T, et al. NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation. J Exp Med. 2018;215:2197-2209 pubmed publisher
|
Chen X, Ma J, Kwan T, Stribos E, Messchendorp A, Loh Y, et al. Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice. Sci Rep. 2018;8:8319 pubmed publisher
|
Zhao J, Yu J, Xu Y, Chen L, Zhou F, Zhai Q, et al. Epidermal HMGB1 Activates Dermal Fibroblasts and Causes Hypertrophic Scar Formation in Reduced Hydration. J Invest Dermatol. 2018;138:2322-2332 pubmed publisher
|
Wang H, Chen Y, Guo J, Shan T, Deng K, Chen J, et al. Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1. Sci Rep. 2018;8:7080 pubmed publisher
|
Sprague L, Lee J, Hutzen B, Wang P, Chen C, Conner J, et al. High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy. Viruses. 2018;10: pubmed publisher
|
Hu J, Vacas S, Feng X, Lutrin D, Uchida Y, Lai I, et al. Dexmedetomidine Prevents Cognitive Decline by Enhancing Resolution of High Mobility Group Box 1 Protein-induced Inflammation through a Vagomimetic Action in Mice. Anesthesiology. 2018;128:921-931 pubmed publisher
|
Kigerl K, Lai W, Wallace L, Yang H, Popovich P. High mobility group box-1 (HMGB1) is increased in injured mouse spinal cord and can elicit neurotoxic inflammation. Brain Behav Immun. 2018;72:22-33 pubmed publisher
|
Wang F, Yang X, Ma Y, Wei Y, Yang M, Chen X, et al. TRIF contributes to epileptogenesis in temporal lobe epilepsy during TLR4 activation. Brain Behav Immun. 2018;67:65-76 pubmed publisher
|
Luan Y, Jia M, Zhang H, Zhu F, Dong N, Feng Y, et al. The potential mechanism of extracellular high mobility group box-1 protein mediated p53 expression in immune dysfunction of T lymphocytes. Oncotarget. 2017;8:112959-112971 pubmed publisher
|
Abu El Asrar A, Alam K, García Ramírez M, Ahmad A, Siddiquei M, Mohammad G, et al. Association of HMGB1 with oxidative stress markers and regulators in PDR. Mol Vis. 2017;23:853-871 pubmed
|
Sun L, Li M, Ma X, Feng H, Song J, Lv C, et al. Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-?B signaling in an IL-6-dependent manner. J Neuroinflammation. 2017;14:231 pubmed publisher
|
Park E, Kim Y, Chang K. Hemin Reduces HMGB1 Release by UVB in an AMPK/HO-1-dependent Pathway in Human Keratinocytes HaCaT Cells. Arch Med Res. 2017;48:423-431 pubmed publisher
|
Elfeky M, Yoneshiro T, Okamatsu Ogura Y, Kimura K. Adiponectin suppression of late inflammatory mediator, HMGB1-induced cytokine expression in RAW 264 macrophage cells. J Biochem. 2017;: pubmed publisher
|
Shimizu K, Kamada Y, Sakamoto A, Matsuda M, Nakatsuka M, Hiramatsu Y. High Expression of High-Mobility Group Box 1 in Menstrual Blood: Implications for Endometriosis. Reprod Sci. 2017;24:1532-1537 pubmed publisher
|
Wong S, To J, Santos J, Allam V, Dalton J, Djordjevic S, et al. Proteomic Analysis of Extracellular HMGB1 Identifies Binding Partners and Exposes Its Potential Role in Airway Epithelial Cell Homeostasis. J Proteome Res. 2017;: pubmed publisher
|
Chang Y, Lin C, Hsieh M, Wu H, Wu W, Wu W, et al. High mobility group B1 up-regulates angiogenic and fibrogenic factors in human retinal pigment epithelial ARPE-19 cells. Cell Signal. 2017;40:248-257 pubmed publisher
|
Zhu J, Wang F, Wang H, Dong N, Zhu X, Wu Y, et al. TNF-α mRNA is negatively regulated by microRNA-181a-5p in maturation of dendritic cells induced by high mobility group box-1 protein. Sci Rep. 2017;7:12239 pubmed publisher
|
Azizan N, Suter M, Liu Y, Logsdon C. RAGE maintains high levels of NF?B and oncogenic Kras activity in pancreatic cancer. Biochem Biophys Res Commun. 2017;493:592-597 pubmed publisher
|
Somensi N, Brum P, de Miranda Ramos V, Gasparotto J, Zanotto Filho A, Rostirolla D, et al. Extracellular HSP70 Activates ERK1/2, NF-kB and Pro-Inflammatory Gene Transcription Through Binding with RAGE in A549 Human Lung Cancer Cells. Cell Physiol Biochem. 2017;42:2507-2522 pubmed publisher
|
Lee I, Kim D, Bae J. Sulforaphane Reduces HMGB1-Mediated Septic Responses and Improves Survival Rate in Septic Mice. Am J Chin Med. 2017;45:1253-1271 pubmed publisher
|
Zhou Y, Han Q, Wang L, Liu T, Meng X, Wu L, et al. High mobility group box 1 protein attenuates myocardial ischemia reperfusion injury via inhibition of the p38 mitogen-activated protein kinase signaling pathway. Exp Ther Med. 2017;14:1582-1588 pubmed publisher
|
Deng H, Wang C, Chang D, Hu N, Chen M, Zhao M. High mobility group box-1 contributes to anti-myeloperoxidase antibody-induced glomerular endothelial cell injury through a moesin-dependent route. Arthritis Res Ther. 2017;19:125 pubmed publisher
|
Choi J, Cui Y, Chowdhury S, Kim B. High-mobility group box-1 as an autocrine trophic factor in white matter stroke. Proc Natl Acad Sci U S A. 2017;114:E4987-E4995 pubmed publisher
|
Tang L, Chai W, Ye F, Yu Y, Cao L, Yang M, et al. HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells. Oncotarget. 2017;8:27314-27327 pubmed publisher
|
Di Candia L, Gomez E, Venereau E, Chachi L, Kaur D, Bianchi M, et al. HMGB1 is upregulated in the airways in asthma and potentiates airway smooth muscle contraction via TLR4. J Allergy Clin Immunol. 2017;140:584-587.e8 pubmed publisher
|
Schaper F, de Leeuw K, Horst G, Maas F, Bootsma H, Heeringa P, et al. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus. Clin Exp Immunol. 2017;188:412-419 pubmed publisher
|
Trinh Q, Pham N, Fuwa K, Takada K, Komine Aizawa S, Honda M, et al. High Mobility Group Box 1 Protein Enhances HIV Replication in Newly Infected Primary T Cells. Clin Lab. 2016;62:2305-2311 pubmed publisher
|
Manfredi A, Rovere Querini P, D Angelo A, Maugeri N. Low molecular weight heparins prevent the induction of autophagy of activated neutrophils and the formation of neutrophil extracellular traps. Pharmacol Res. 2017;123:146-156 pubmed publisher
|
Chen X, Fang D, Li L, Chen L, Li Q, Gong F, et al. Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells. Immunol Res. 2017;65:666-680 pubmed publisher
|
Zhu X, Chen X, Wang W, Li X, Huo J, Wang Y, et al. Electroacupuncture pretreatment attenuates spinal cord ischemia-reperfusion injury via inhibition of high-mobility group box 1 production in a LXA4 receptor-dependent manner. Brain Res. 2017;1659:113-120 pubmed publisher
|
Su Z, Ni P, She P, Liu Y, Richard S, Xu W, et al. Bio-HMGB1 from breast cancer contributes to M-MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC-like cells. Cancer Immunol Immunother. 2017;66:391-401 pubmed publisher
|
Min G, Ku S, Park M, Park T, Lee H, Bae J. Anti-septic effects of pelargonidin on HMGB1-induced responses in vitro and in vivo. Arch Pharm Res. 2016;39:1726-1738 pubmed publisher
|
Yang J, Zhao Y, Zhang P, Li Y, Yang Y, Yang Y, et al. Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis: role in pulmonary inflammation following LPS. Cell Death Dis. 2016;7:e2363 pubmed publisher
|
Zheng S, Kummarapurugu A, Afosah D, Sankaranarayanan N, Boothello R, Desai U, et al. 2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity. Am J Respir Cell Mol Biol. 2017;56:90-98 pubmed publisher
|
Wang K, Li W, Yu Q, Guo B, Yang B, Zhang C, et al. High Mobility Group Box 1 Mediates Interferon-γ-Induced Phenotypic Modulation of Vascular Smooth Muscle Cells. J Cell Biochem. 2017;118:518-529 pubmed publisher
|
Shang D, Peng T, Gou S, Li Y, Wu H, Wang C, et al. High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway. Sci Rep. 2016;6:32180 pubmed publisher
|
Li J, Huang L, Wang S, Yao Y, Zhang Z. Astragaloside IV attenuates inflammatory reaction via activating immune function of regulatory T-cells inhibited by HMGB1 in mice. Pharm Biol. 2016;54:3217-3225 pubmed
|
Mohammad G, Jomar D, Siddiquei M, Alam K, Abu El Asrar A. High-Mobility Group Box-1 Protein Mediates the Regulation of Signal Transducer and Activator of Transcription-3 in the Diabetic Retina and in Human Retinal Müller Cells. Ophthalmic Res. 2017;57:150-160 pubmed publisher
|
Xu J, Wang H, Won S, Basu J, Kapfhamer D, Swanson R. Microglial activation induced by the alarmin S100B is regulated by poly(ADP-ribose) polymerase-1. Glia. 2016;64:1869-78 pubmed publisher
|
Li Z, Scott M, Fan E, Li Y, Liu J, Xiao G, et al. Tissue damage negatively regulates LPS-induced macrophage necroptosis. Cell Death Differ. 2016;23:1428-47 pubmed publisher
|
Lai C, Wang K, Lee F, Tsai H, Ma C, Cheng T, et al. Toll-Like Receptor 4 Is Essential in the Development of Abdominal Aortic Aneurysm. PLoS ONE. 2016;11:e0146565 pubmed publisher
|
Chen Y, Statt S, Wu R, Chang H, Liao J, Wang C, et al. High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Sci Rep. 2016;6:18815 pubmed publisher
|
Ma Y, Ma T, Wang C, Wang H, Chang D, Chen M, et al. High-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation. Arthritis Res Ther. 2016;18:2 pubmed publisher
|
Man L, Liu F, Wang Y, Song H, Xu H, Zhu Z, et al. The HMGB1 signaling pathway activates the inflammatory response in Schwann cells. Neural Regen Res. 2015;10:1706-12 pubmed publisher
|
Yao H, Zhou M, Zhou Y, Wang L, Zhang D, Han Q, et al. Intravenous high mobility group box 1 upregulates the expression of HIF-1α in the myocardium via a protein kinase B-dependent pathway in rats following acute myocardial ischemia. Mol Med Rep. 2016;13:1211-9 pubmed publisher
|
Appavoo E, Hajam I, Muneeswaran N, Kondabattula G, Bhanuprakash V, Kishore S. Synergistic effect of high-mobility group box-1 and lipopolysaccharide on cytokine induction in bovine peripheral blood mononuclear cells. Microbiol Immunol. 2016;60:196-202 pubmed publisher
|
Shao M, Tang S, Liu B, Zhu H. Rac1 mediates HMGB1‑induced hyperpermeability in pulmonary microvascular endothelial cells via MAPK signal transduction. Mol Med Rep. 2016;13:529-35 pubmed publisher
|
Wang B, Li F, Zhang C, Wei G, Liao P, Dong N. High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells. J Thorac Cardiovasc Surg. 2016;151:255-62 pubmed publisher
|
Liu Z, Wang Z, Han G, Huang L, Jiang J, Li S. Ketamine attenuates high mobility group box-1-induced inflammatory responses in endothelial cells. J Surg Res. 2016;200:593-603 pubmed publisher
|
Ojo O, Ryu M, Jha A, Unruh H, Halayko A. High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2015;309:L1354-66 pubmed publisher
|
Zhu X, Sun L, Wang Y. High mobility group box 1 (HMGB1) is upregulated by the Epstein-Barr virus infection and promotes the proliferation of human nasopharyngeal carcinoma cells. Acta Otolaryngol. 2016;136:87-94 pubmed publisher
|
Zheng S, Pan Y, Wang C, Liu Y, Shi M, Ding G. HMGB1 Turns Renal Tubular Epithelial Cells into Inflammatory Promoters by Interacting with TLR4 During Sepsis. J Interferon Cytokine Res. 2016;36:9-19 pubmed publisher
|
Chen Y, Pitzer A, Li X, Li P, Wang L, Zhang Y. Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of HMGB1. J Cell Mol Med. 2015;19:2715-27 pubmed publisher
|
Chen Y, Qiao F, Zhao Y, Wang Y, Liu G. HMGB1 is activated in type 2 diabetes mellitus patients and in mesangial cells in response to high glucose. Int J Clin Exp Pathol. 2015;8:6683-91 pubmed
|
Lee W, Yoon E, Kim K, Park D, Bae J. Antiseptic effect of vicenin-2 and scolymoside from Cyclopia subternata (honeybush) in response to HMGB1 as a late sepsis mediator in vitro and in vivo. Can J Physiol Pharmacol. 2015;93:709-20 pubmed publisher
|
Kwak S, Ku S, Kang H, Baek M, Bae J. Methylthiouracil, a new treatment option for sepsis. Vascul Pharmacol. 2017;88:1-10 pubmed publisher
|
Lee W, Kim K, Bae J. Ameliorative Effect of Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) on HMGB1-Induced Septic Responses In Vitro and In Vivo. Am J Chin Med. 2015;43:991-1012 pubmed publisher
|
Yang E, Ku S, Lee W, Song K, Bae J. Inhibitory effects of polyozellin from Polyozellus multiplex on HMGB1-mediated septic responses. Inflamm Res. 2015;64:733-46 pubmed publisher
|
Ahrens I, Chen Y, Topcic D, Bode M, Haenel D, Hagemeyer C, et al. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi. Thromb Haemost. 2015;114:994-1003 pubmed publisher
|
Good D, George T, Watts B. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway. Am J Physiol Renal Physiol. 2015;309:F720-30 pubmed publisher
|
Liu Z, Du R, Long J, Guo K, Ge C, Bi S, et al. microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression. Chin J Cancer Res. 2015;27:267-78 pubmed publisher
|
Zhu L, Ren L, Chen Y, Fang J, Ge Z, Li X. Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma. J Cell Mol Med. 2015;19:2128-35 pubmed publisher
|
Mohammad G, Alam K, Nawaz M, Siddiquei M, Mousa A, Abu El Asrar A. Mutual enhancement between high-mobility group box-1 and NADPH oxidase-derived reactive oxygen species mediates diabetes-induced upregulation of retinal apoptotic markers. J Physiol Biochem. 2015;71:359-72 pubmed publisher
|
Zhang W, Lavine K, Epelman S, Evans S, Weinheimer C, Barger P, et al. Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo. J Am Heart Assoc. 2015;4:e001993 pubmed publisher
|
Lee W, Kwon O, Han M, Lee Y, Kim S, Kim K, et al. Role of moesin in HMGB1-stimulated severe inflammatory responses. Thromb Haemost. 2015;114:350-63 pubmed publisher
|
Wang C, Wang H, Hao J, Chang D, Zhao M, Chen M. Involvement of high mobility group box 1 in the activation of C5a-primed neutrophils induced by ANCA. Clin Immunol. 2015;159:47-57 pubmed publisher
|
Lee W, Ku S, Na D, Bae J. Anti-Inflammatory Effects of Lysozyme Against HMGB1 in Human Endothelial Cells and in Mice. Inflammation. 2015;38:1911-24 pubmed publisher
|
Ma T, Wang H, Wang C, Chang D, Zhao M, Chen M. Urinary levels of high mobility group box-1 are associated with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis. PLoS ONE. 2015;10:e0123586 pubmed publisher
|
Gargus M, Niu C, Vallone J, Binkley J, Rubin D, Shaker A. Human esophageal myofibroblasts secrete proinflammatory cytokines in response to acid and Toll-like receptor 4 ligands. Am J Physiol Gastrointest Liver Physiol. 2015;308:G904-23 pubmed
|
Matena J, Petersen S, Gieseke M, Kampmann A, Teske M, Beyerbach M, et al. SLM produced porous titanium implant improvements for enhanced vascularization and osteoblast seeding. Int J Mol Sci. 2015;16:7478-92 pubmed publisher
|
Chung H, Jang S, Kim H, Lim J. Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancer. Int J Cancer. 2015;137:1598-609 pubmed publisher
|
Wu T, Liu L, Zhang W, Zhang Y, Liu Y, Shen X, et al. High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior. J Psychiatr Res. 2015;64:99-106 pubmed publisher
|
Liu W, Zhang Z, Zhang Y, Chen X, Guo S, Lei Y, et al. HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway. Cancer Biol Ther. 2015;16:511-7 pubmed publisher
|
Lee W, Park E, Kwak S, Kim Y, Na D, Bae J. PEGylated lysozymes with anti-septic effects in human endothelial cells and in mice. Biochem Biophys Res Commun. 2015;459:662-7 pubmed publisher
|
Kim I, Luo L, Lee H, Lee H, Lee J. HMGB1-binding heptamer suppresses the synergistic effect of HMGB1 and LPS by interacting directly with HMGB1. Neurosci Lett. 2015;593:40-4 pubmed publisher
|
Lee W, Kwak S, Yun E, Lee J, Na M, Song G, et al. Antiseptic Effects of New 3'-N-Substituted Carbazole Derivatives In Vitro and In Vivo. Inflammation. 2015;38:1649-61 pubmed publisher
|
Liu X, Yu D, Chen M, Sun T, Li G, Huang W, et al. Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release. Int Immunopharmacol. 2015;25:370-6 pubmed publisher
|
Zhang Q, Wu L, Zhang T, Han Y, Lin X. Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2. Oncol Rep. 2015;33:1630-8 pubmed publisher
|
Yu S, Wong C, Szeto C, Li E, Cai Z, Tam L. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis. Lupus. 2015;24:675-86 pubmed publisher
|
Wen Z, Fan L, Li Y, Zou Z, Scott M, Xiao G, et al. Neutrophils counteract autophagy-mediated anti-inflammatory mechanisms in alveolar macrophage: role in posthemorrhagic shock acute lung inflammation. J Immunol. 2014;193:4623-33 pubmed publisher
|
Tripisciano C, Eichhorn T, Harm S, Weber V. Adsorption of the inflammatory mediator high-mobility group box 1 by polymers with different charge and porosity. Biomed Res Int. 2014;2014:238160 pubmed publisher
|
Hou C, Kong J, Liang Y, Huang H, Wen H, Zheng X, et al. HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts. Cell Mol Immunol. 2015;12:409-23 pubmed publisher
|
Duan E, Wang D, Luo R, Luo J, Gao L, Chen H, et al. Porcine reproductive and respiratory syndrome virus infection triggers HMGB1 release to promote inflammatory cytokine production. Virology. 2014;468-470:1-9 pubmed publisher
|
Kim H, Park S, Lee S, Lee H, Lee W, Rhim B, et al. Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis. PLoS ONE. 2014;9:e104743 pubmed publisher
|
Li Q, Li J, Wen T, Zeng W, Peng C, Yan S, et al. Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway. Oncotarget. 2014;5:6387-403 pubmed
|
Jessop F, Holian A. Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo. Nanotoxicology. 2015;9:365-72 pubmed publisher
|
Li M, Sun L, Li Y, Xie C, Wan D, Luo Y. Oxygen glucose deprivation/reperfusion astrocytes promotes primary neural stem/progenitor cell proliferation by releasing high-mobility group box 1. Neurochem Res. 2014;39:1440-50 pubmed publisher
|
Lee W, Ku S, Park E, Na D, Kim K, Bae J. Exendin-4 inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis. Inflammation. 2014;37:1876-88 pubmed publisher
|
Thaxton J, Liu B, Zheng P, Liu Y, Li Z. Deletion of CD24 impairs development of heat shock protein gp96-driven autoimmune disease through expansion of myeloid-derived suppressor cells. J Immunol. 2014;192:5679-86 pubmed publisher
|
Yoo H, Ku S, Lee T, Bae J. Orientin inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis. Inflammation. 2014;37:1705-17 pubmed publisher
|
Yoo H, Ku S, Han M, Kim K, Bae J. Anti-septic effects of fisetin in vitro and in vivo. Inflammation. 2014;37:1560-74 pubmed publisher
|
Xu X, Zhu H, Wang T, Sun Y, Ni P, Liu Y, et al. Exogenous high-mobility group box 1 inhibits apoptosis and promotes the proliferation of lewis cells via RAGE/TLR4-dependent signal pathways. Scand J Immunol. 2014;79:386-94 pubmed publisher
|
Hayakawa K, Pham L, Arai K, Lo E. Reactive astrocytes promote adhesive interactions between brain endothelium and endothelial progenitor cells via HMGB1 and beta-2 integrin signaling. Stem Cell Res. 2014;12:531-8 pubmed publisher
|
Li P, Bledsoe G, Yang Z, Fan H, Chao L, Chao J. Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis. Immunology. 2014;142:216-26 pubmed publisher
|
Nehil M, Paquette J, Tokuyasu T, McCormick F. High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A. Oncogene. 2014;33:5151-62 pubmed publisher
|
Su Z, Sun C, Zhou C, Liu Y, Zhu H, Sandoghchian S, et al. HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion. Eur J Immunol. 2011;41:3586-95 pubmed publisher
|
Su X, Matthay M, Malik A. Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. J Immunol. 2010;184:401-10 pubmed publisher
|
Lu W, Peterson R, Dasgupta A, Scovell W. Influence of HMG-1 and adenovirus oncoprotein E1A on early stages of transcriptional preinitiation complex assembly. J Biol Chem. 2000;275:35006-12 pubmed
|
Taguchi A, Blood D, Del Toro G, Canet A, Lee D, Qu W, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 2000;405:354-60 pubmed
|
Ellwood K, Yen Y, Johnson R, Carey M. Mechanism for specificity by HMG-1 in enhanceosome assembly. Mol Cell Biol. 2000;20:4359-70 pubmed
|
Wang H, Bloom O, Zhang M, Vishnubhakat J, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248-51 pubmed
|
Jayaraman L, Moorthy N, Murthy K, Manley J, Bustin M, Prives C. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev. 1998;12:462-72 pubmed
|
Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol. 1996;54:35-100 pubmed
|
Parkkinen J, Raulo E, Merenmies J, Nolo R, Kajander E, Baumann M, et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem. 1993;268:19726-38 pubmed
|
Onate S, Prendergast P, Wagner J, Nissen M, Reeves R, Pettijohn D, et al. The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol. 1994;14:3376-91 pubmed
|
Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen J, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem. 1995;270:25752-61 pubmed
|